#Needle-Free Drug Delivery Systems Market
Text
North America holds the prominent share in Global Needle-Free Drug-Device Market.
0 notes
Text
Prefilled Syringes Market Trends, Challenges, In-Depth Insights, Strategies (2023-2030)
The global prefilled syringes market is poised for remarkable expansion, with projections indicating a surge to a staggering US$41.85 billion by the year 2030, up from US$18.7 billion recorded in 2022. This substantial growth trajectory, marked by a robust Compound Annual Growth Rate (CAGR) of 12.2% between 2023 and 2030, reflects a burgeoning demand for prefilled syringes driven by multiple key factors.
For More Industry Insight: https://www.fairfieldmarketresearch.com/report/prefilled-syringes-market
Precise Dosing and Enhanced Safety Fuel Market Expansion
One of the primary drivers behind the escalating demand for prefilled syringes is their ability to offer precise dosing and mitigate the risk of contamination. As the pharmaceutical landscape witnesses a surge in the popularity of biologics and biosimilars, the need for accurate delivery mechanisms has become paramount. Prefilled syringes emerge as an optimal solution, ensuring the precise administration of intricate therapies with reduced contamination risks, thus catalyzing market growth.
Rapidly Expanding Healthcare Sector Spurs Market Adoption
Moreover, the exponential growth of the healthcare sector worldwide has significantly contributed to the increasing uptake of prefilled syringes. With a focus on enhancing patient safety and mitigating needlestick injuries, prefilled syringes equipped with safety features such as auto-injectors, needle shields, and tamper-evident seals have garnered substantial traction. These safety mechanisms not only safeguard healthcare workers but also inspire confidence among patients, thereby fostering market expansion.
Market Trends and Opportunities
The market landscape is characterized by a slew of trends and opportunities poised to shape the trajectory of prefilled syringes adoption. Notably, the escalating demand for biologics and biosimilars underscores the pivotal role of prefilled syringes in facilitating precise dosing and contamination-free administration. Additionally, advancements in drug delivery systems, coupled with the rising preference for self-care among patients, are expected to further drive market growth.
Regulatory Support and Technological Innovations Propel Market Momentum
Regulatory endorsements, particularly from entities such as the FDA and EMA, have played a pivotal role in bolstering the adoption of prefilled syringes by pharmaceutical companies. Furthermore, ongoing technological innovations have enhanced the performance and safety of prefilled syringes, making them increasingly popular among both patients and healthcare professionals.
Challenges and Barriers
Despite the remarkable growth prospects, the market is not devoid of challenges. High production costs pose a significant barrier, as leading market players prioritize efficiency and quality, albeit at elevated production expenses. Additionally, regulatory restrictions and supply chain disruptions, particularly concerning the availability of high-quality glass, present notable impediments to market growth.
Regional Outlook
Europe stands at the forefront of prefilled syringes adoption, driven by robust R&D investments and a surge in chronic disorders. Meanwhile, the Asia Pacific region is poised to witness accelerated growth, buoyed by a rapidly evolving healthcare landscape and increasing technical advancements.
Key Players in the Global Prefilled Syringes Market
The global prefilled syringes market is characterized by the presence of key players such as Stevanato Group SPA, Baxter Healthcare Corporation, Gerresheimer AG, Aptar Pharma, Becton Dickinson and Company, Lonza, West Pharmaceutical Services, Inc., and others. These industry stalwarts are focused on introducing innovative products and expanding their global footprint to capitalize on burgeoning market opportunities.
0 notes
Text
Smart Syringe Market Challenges and Opportunities, Key Industry Players and Market Forecast-2032
The global smart syringe market has experienced remarkable growth, reaching a value of USD 10,157.16 million in 2023. This growth can be attributed to the increasing adoption of smart syringes, which offer advanced features such as automatic retractable needles, dose measurement, and safety mechanisms to prevent needlestick injuries and medication errors. The forecast period from 2024 to 2032 is expected to witness continued growth in the market, with a projected compound annual growth rate (CAGR) of 9.7%. By 2032, the market is anticipated to reach a value of USD 23,321.73 million, driven by factors such as the rising prevalence of chronic diseases, growing demand for safe and efficient drug delivery systems, and increasing investments in healthcare infrastructure worldwide. Additionally, stringent regulations promoting the adoption of safety-engineered medical devices, along with technological advancements in smart syringe design and manufacturing, are further expected to fuel market growth. Overall, the global smart syringe market presents significant opportunities for manufacturers, healthcare providers, and patients alike, promising safer and more effective medication administration practices.
Key Industry Players
B. Braun Melsungen AG
Terumo Corporation
Smiths Group plc
Becton, Dickinson and Company
Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/smart-syringe-market/requestsample
#Smart Syringe Market Size#Smart Syringe Market Share#Smart Syringe Market Growth#Smart Syringe Market
0 notes
Text
Nasal Drug Delivery Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2031
In recent years, the nasal drug delivery market has witnessed remarkable growth, driven by advancements in drug delivery technologies and the increasing prevalence of chronic diseases. According to recent estimates, the market was valued at USD 71.9 billion in 2022, and it is projected to reach USD 128.7 billion by 2030, with a compound annual growth rate (CAGR) of approximately 7.55% during the forecast period of 2023-2030. This substantial growth trajectory underscores the expanding role of nasal drug delivery in modern healthcare.
Emerging Trends and Opportunities
Several trends are shaping the landscape of the nasal drug delivery market. One notable trend is the growing adoption of nasal sprays and drops for the treatment of various respiratory conditions, such as allergic rhinitis, sinusitis, and nasal congestion. These non-invasive delivery methods offer convenience and effectiveness, driving their widespread acceptance among patients and healthcare providers.
Moreover, advancements in formulation technologies are enabling the development of novel nasal drug delivery systems with improved efficacy and patient compliance. Nasal drug delivery devices equipped with smart features, such as dose tracking and reminders, are gaining traction, enhancing medication adherence and management.
Furthermore, the expansion of the nasal drug delivery market beyond respiratory indications is opening up new avenues for growth. Nasal delivery is being explored for the administration of vaccines, hormones, and central nervous system (CNS) drugs, presenting lucrative opportunities for pharmaceutical companies and device manufacturers.
Download Free Sample Copy of Report: https://www.snsinsider.com/sample-request/3046
Key Drivers Propelling Growth
Several factors are fueling the growth of the nasal drug delivery market. One of the primary drivers is the increasing prevalence of chronic respiratory diseases, including asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. The rising burden of these conditions is driving the demand for effective and convenient treatment options, thereby boosting the adoption of nasal drug delivery systems.
Additionally, the growing focus on patient-centric healthcare solutions is driving the demand for non-invasive drug delivery methods that offer enhanced comfort and convenience. Nasal drug delivery devices provide a needle-free and painless alternative to injections, making them particularly appealing to patients, especially children and elderly individuals.
Moreover, advancements in drug formulation and delivery technologies are expanding the therapeutic capabilities of nasal drug delivery systems. The development of nanoformulations and mucoadhesive formulations enables targeted and sustained drug release, improving the efficacy and duration of action of nasal medications.
Challenges and Considerations
Despite the promising growth prospects, the nasal drug delivery market faces certain challenges that warrant consideration. One such challenge is the regulatory landscape governing nasal drug products. Stringent regulatory requirements, particularly concerning safety and efficacy, can pose barriers to market entry for new products and innovations.
Furthermore, the variability in nasal anatomy and physiology among individuals can affect the performance and effectiveness of nasal drug delivery systems. Achieving consistent and reliable drug delivery across diverse patient populations remains a significant challenge for manufacturers and developers.
Moreover, competition from alternative drug delivery routes, such as oral and pulmonary delivery, poses a challenge to the growth of the nasal drug delivery market. To maintain a competitive edge, companies need to demonstrate the unique advantages and value proposition of nasal drug delivery over other routes of administration.
Key Takeaways from the Market
In conclusion, the nasal drug delivery market is poised for significant growth in the coming years, driven by emerging trends, technological advancements, and favorable market dynamics. Key takeaways from the market include the growing adoption of nasal drug delivery for respiratory and non-respiratory indications, driven by the increasing prevalence of chronic diseases and the demand for patient-centric healthcare solutions.
Furthermore, opportunities abound for companies to leverage advancements in formulation technologies and device innovations to develop differentiated nasal drug delivery products with enhanced efficacy and patient compliance. However, navigating the regulatory landscape and addressing challenges related to anatomical variability and competition will be crucial for success in this dynamic and evolving market. Overall, the future looks promising for the nasal drug delivery market, with ample opportunities for growth and innovation.
Other Report
Medical Collagen Market
0 notes
Text
0 notes
Text
Intranasal Drug and Vaccine Delivery Market: Emerging Trends, Growth Prospects and Industry Forecast 2023-2032
Introduction:
The landscape of drug and vaccine administration is undergoing a paradigm shift with the rise of intranasal delivery methods. This article explores the trends and innovations shaping the Global Intranasal Drug and Vaccine Delivery Market, unveiling a future where therapeutic horizons are expanded through non-invasive and patient-friendly approaches.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 𝐑𝐞𝐩𝐨𝐫𝐭 : https://www.alliedmarketresearch.com/request-toc-and-sample/8792
Accelerated Research and Development (R&D):
The COVID-19 pandemic has spurred an unprecedented collaborative effort between pharmaceutical and biotech companies globally. With around 115 vaccine candidates and 155 molecules in the research and development pipeline, the industry is witnessing an accelerated pace of innovation. This surge in R&D activity not only reflects the urgency to develop effective vaccines and treatments but also signifies a paradigm shift in how the industry responds to global health crises.
Supply Chain Challenges and Opportunities:
The pharmaceutical supply chain has faced significant challenges during the COVID-19 pandemic, with disruptions in manufacturing, distribution, and logistics. However, this scenario has also presented opportunities for companies to reevaluate and strengthen their supply chain resilience. Manufacturers of COVID-19 management drugs, including commonly used drugs like hydroxychloroquine, have seen a surge in demand. This increased demand not only addresses immediate shortages but also highlights the potential for growth in the pharmaceutical and biotechnology industries.
Future Growth Prospects:
The demand for vaccines and treatment drugs for COVID-19 is expected to have a lasting impact on the pharmaceutical and biotechnology industries. As the world continues to grapple with the ongoing pandemic and prepares for potential future outbreaks, these industries are positioned for significant growth. The lessons learned from the challenges faced during the COVID-19 crisis are likely to drive investments in research, development, and manufacturing capabilities, shaping the future landscape of healthcare and biopharmaceuticals.
𝐏𝐫𝐞-𝐛𝐨𝐨𝐤 𝐭𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 𝐍𝐨𝐰 : https://www.alliedmarketresearch.com/intranasal-drug-and-vaccine-delivery-market/purchase-options
Intranasal Delivery: A Gateway to Therapeutic Transformation
Intranasal drug and vaccine delivery are emerging as game-changers in the healthcare industry, offering a less invasive and more patient-friendly alternative to traditional administration methods. This section delves into the key advantages of intranasal delivery, such as rapid absorption, bypassing the digestive system, and the potential for enhanced therapeutic efficacy. As the world seeks more convenient and efficient healthcare solutions, intranasal delivery stands at the forefront of this transformative wave.
Innovations Driving the Market Forward
The Global Intranasal Drug and Vaccine Delivery Market are propelled by continuous innovations and advancements. From needle-free devices to novel formulations designed for efficient intranasal absorption, the market is witnessing a surge in groundbreaking technologies. This article explores recent innovations, highlighting how they are poised to redefine the landscape of drug and vaccine delivery. It also touches upon the role of research and development in shaping these transformative solutions.
Therapeutic Horizons: Expanding Applications and Treatments
The versatility of intranasal drug and vaccine delivery extends beyond its convenience; it opens up new therapeutic horizons across a spectrum of medical conditions. This section explores the expanding applications of intranasal delivery, from neurological disorders to infectious diseases. The ability to deliver drugs directly to the central nervous system and mount effective immune responses against respiratory infections positions intranasal administration as a powerful tool for future therapeutic interventions.
Market Dynamics and Growth Outlook
Analyzing the market dynamics provides valuable insights into the growth scenario of intranasal drug and vaccine delivery. The article quantitatively explores current market conditions, shedding light on trends that are shaping the future. Factors such as increasing R&D investments, strategic partnerships, and regulatory support are discussed to provide a comprehensive outlook on the market's trajectory.
𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐭𝐨 𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐭𝐡𝐞 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡 𝐑𝐞𝐩𝐨𝐫𝐭? 𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐮𝐲𝐢𝐧𝐠 : https://www.alliedmarketresearch.com/purchase-enquiry/8792
Future Perspectives: Navigating Toward Enhanced Patient Care
The article concludes by looking ahead at the future perspectives of the Global Intranasal Drug and Vaccine Delivery Market. Anticipated trends, technological breakthroughs, and the potential impact on patient care are explored. As the world moves towards patient-centric healthcare solutions, intranasal drug and vaccine delivery are poised to play a pivotal role in shaping a future where therapeutic horizons are broadened, and healthcare becomes more accessible and efficient.
Conclusion: The Global Intranasal Drug and Vaccine Delivery Market are on the cusp of transformative growth, unveiling future therapeutic horizons that promise enhanced patient care and treatment efficacy. As innovations continue to unfold, intranasal delivery stands as a beacon of progress, redefining how we administer therapeutics and envisioning a future where healthcare is not just effective but also more patient-friendly.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
0 notes
Text
0 notes
Text
Prefilled Needle Free Injector Market Size, Type, segmentation, growth and forecast 2023-2030
Prefilled Needle Free Injector Market
The Prefilled Needle Free Injector Market is expected to grow from USD 662.00 Million in 2022 to USD 1581.46 Million by 2030, at a CAGR of 11.50% during the forecast period.
Get the Sample Report: https://www.reportprime.com/enquiry/sample-report/10210
Prefilled Needle Free Injector Market Size
The Prefilled Needle Free Injector market research report analyzes the market segment based on type, application, and region, with key players including Antares Pharma Inc, Endo International, Pharma Jet, Bioject Medical Technologies, Medical International Technology Inc, INJEX Pharama AG, National Medical Products Inc, Valeritas Inc, European Pharma Group, PenJet Corporation, and Crossject SA. The report covers regulatory and legal factors specific to market conditions. Prefilled Needle Free Injectors are available as reusable or disposable versions and are used in hospitals, clinics, and other healthcare settings. The market is segmented into North America, Asia Pacific, Middle East, Africa, Australia and Europe. The report provides insights into market trends, growth drivers, challenges, and opportunities. The Prefilled Needle Free Injector market is expected to witness significant growth in the coming years due to the increasing demand for painless drug delivery, rising prevalence of chronic diseases, and increasing investment by key players in research and development. Regulatory and legal factors specific to the market conditions will also have a significant impact on market growth.
Prefilled Needle Free Injector Market Key Player
Antares Pharma Inc
Endo International
Pharma Jet
Bioject Medical Technologies
Medical International Technology Inc
Buy Now & Get Exclusive Discount on this https://www.reportprime.com/enquiry/request-discount/10210
Prefilled Needle Free Injector Market Segment Analysis
The Prefilled Needle-Free Injector target market is rapidly growing as more healthcare providers seek alternatives to traditional needle-based injections. The key driving factors of revenue growth in the Prefilled Needle-Free Injector market include ease of use, reduced risk of needlestick injuries, improved patient satisfaction, and faster administration times. Additionally, the increasing prevalence of chronic diseases and the rising need for vaccines is fueling the demand for prefilled needle-free injectors globally.
The latest trends in the Prefilled Needle-Free Injector market include the development of innovative technologies such as jet injectors, advancements in drug-delivery systems, and the increasing adoption of prefilled syringes. Furthermore, the rising adoption of these injectors in emerging economies and increased funding for research and development activities are expected to create new opportunities in the market.
Despite the numerous growth opportunities, the Prefilled Needle-Free Injector market still faces some challenges that could hinder its progress. Some of these challenges include the high cost of the injectors, potential adverse reactions to injectable drugs, and limitations on the viscosity of drugs that can be injected with these devices. Additionally, the lack of awareness and training regarding the use of prefilled needle-free injectors in healthcare providers and the general population could also limit their adoption.
In conclusion, the Prefilled Needle-Free Injector market is expected to experience significant growth in the coming years, driven by factors such as increasing chronic diseases and the need for faster injection administration. However, there are still challenges that must be addressed, such as drug compatibility limitations and higher costs, to continue the growth trajectory in the market. The report's main findings conclude that companies in the market need to focus on developing innovative technologies and improving awareness regarding the use of these devices to overcome these challenges and further grow the market.
This report covers impact on COVID-19 and Russia-Ukraine wars in detail.
Purchase This Report: https://www.reportprime.com/checkout?id=10210&price=3590
Market Segmentation (by Application):
Hospital
Clinic
Others
Information is sourced from www.reportprime.com
0 notes
Text
Pen Needle Market Statistics and Global Analysis Report 2030
The growth of the pen needles market is primarily fueled by increased awareness among consumers. Favorable reimbursement policies and the widespread adoption of pen needles have led to a rise in self-administered insulin usage through insulin pens. The market is also influenced by the trend towards minimally invasive procedures, driven by shorter hospital stays, reduced trauma, and the higher prevalence of chronic conditions like diabetes and obesity. Additionally, factors such as the growing elderly population, improvements in healthcare systems, increased health awareness among consumers, and technological innovations are all contributing to the positive trajectory of the pen needles market. Market players are positioned to capitalize on favorable opportunities during the projected period from 2022 to 2030, driven by the rising demand for biosimilar medications.
Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/pen-needle-market/
The market for safety pen needles has seen an increase in diabetes cases worldwide due to lifestyle changes and a rise in genetic factors among the global population. According to data from the Centers for Disease Control and Prevention (CDC), around 10.5% of the American population (equivalent to 34.2 million individuals) had diabetes, with 26.9 million diagnosed cases and 7.3 million undiagnosed cases. This substantial diabetic population is expected to propel sales growth in the safety pen needles throughout the forecast period.
Global Pen Needle Market Amid COVID-19 Pandemic
The impact of COVID-19 hit various industries hard, and one of those affected was the safety pen needle market, especially as the number of global COVID-19 cases increased. In recent times, there’s been a shortage of important medical supplies and basic medical equipment. The necessity to control the spread of diseases has caused a surge in the demand for specific medical supplies and equipment. We’ve also seen an increase in the overall number of cases, infectious diseases, and mortality rates. More people are requiring critical care, ventilator support, and medical assistance, which means there’s a need for more medical staff and specialists.
The COVID-19 pandemic made a significant impact on over 100 countries, leading the World Health Organization (WHO) to declare it a public health emergency. According to WHO’s estimates, the coronavirus (COVID-19) has infected around 166 million individuals globally.
COVID-19 has influenced the economy in several ways, disrupting supply and demand, causing issues in distribution chains, and affecting businesses and stock markets. Moreover, the healthcare system in the United States saw a noticeable decrease in surgical procedures between March 2022 and June 2022 compared to the same period the prior year. The pandemic had widespread effects on major economies like the US, China, Japan, and various European nations. In response to the growing presence of COVID-19, key players in the US pen needles market are concentrating on creating innovative solutions to lessen the impact of the disease. Both the US and the global economies have felt profound consequences due to the COVID-19 pandemic.
Increasing Prevalence of Chronic Diseases, and Adoption of Novel Drug Delivery Systems, Consumer Awareness & Technological Trends to Boost Global Pen Needle Market
The growth of the pen needles market is being pushed by several factors. These include increased awareness among consumers, favorable reimbursement options, and the wider use of pen needles for self-administering insulin. The market is also being shaped by the trend toward less invasive procedures, shorter hospital stays, the growing occurrence of chronic conditions like diabetes and obesity, the aging population, investments in healthcare systems, people’s heightened awareness of their health, and advancements in technology. The period projected from 2022 to 2030 is anticipated to offer profitable opportunities for market players due to the rising demand for biosimilar medications.
In the pen needles market, a significant factor is the rise in global diabetes cases due to changes in lifestyle and genetic mutations. The CDC’s data shows a substantial number of Americans dealing with diabetes, which is expected to contribute to increased sales in the global pen needles market throughout the forecast period.
Devices for self-injection, particularly pens used for giving biopharmaceuticals subcutaneously, are gaining prominence in the drug delivery device market. The demand for these devices is on the rise because of the introduction of new injectables, the preference for at-home treatments, and the desire for improved patient comfort. The market is witnessing the introduction of next-generation pen needles with enhanced features that benefit both healthcare professionals and patients.
North America to Spearhead the Global Pen Needle Market
The world’s population is aging quickly, particularly in advanced economies like the United States. The World Health Organization (WHO) estimates that the number of elderly people worldwide will increase from 900 million in 2022 to around 2000 million (22% of the world’s population) by 2030. Due to substantial alterations in lifestyle, an increase in malnutrition cases, and genetic abnormalities in the area, it is anticipated that the prevalence of diabetes in North America will climb tremendously in the upcoming years.
Increasing occurrence of chronic disorders: One of the main potential growth elements thought to be responsible for the increased prevalence of chronic diseases in this area is the clinical urgency to use these items.
Favorable Regulatory Environment: The regulatory climate in North America is improving. Pharmaceutical businesses are finding it simpler to launch new drugs since regulatory agencies are creating clearer policies and procedures for the clearance of these therapies.
Adoption of new technology: Adoption of new technologies by the major industries to develop effective medical equipment.
New product development: Intensive new product development activities are carried out to meet the needs demanded by the people for the treatment.
Increased investment in Health care infrastructure: Due to the increase in investment in the healthcare segment North America is leading the drug-device combination products market.
Make The Smart Decision. Download A Free Sample Of Our Report @ https://cognizancemarketresearch.com/request/pen-needle-market/
Some of the key players operating in the global pen needles market are Becton Dickinson and Company (U.S.), Novo Nordisk A/S (Denmark), Ypsomed Holding AG (Switzerland), UltiMed, Inc. (U.S.), Allison Medical, Inc. (U.S.), Owen Mumford, Ltd. (U.K.), B. Braun Melsungen (Germany), Artsana S.p.a. (Italy), HTL-STREFA S.A. (Poland), Terumo Corporation (Japan), Links Medical Products Inc., Arkray Inc., McKesson Medical-Surgical Inc.
0 notes
Text
Prefilled Syringes Market Analysis of Market Size, Share & Trends is anticipated to reach USD 32.3 billion by 2032
Fatpos Global has released a report titled “Prefilled Syringes Market — Analysis of Market Size, Share & Trends for 2021–2022 and Forecasts to 2032” which is anticipated to reach USD 32.3 billion by 2032. According to a study by Fatpos Global, the market is expected to portray a CAGR of 10.9% between 2022 and 2032. According to the market research study, growing incidence of chronic diseases like autoimmune diseases, diabetes etc., requiring usage of prefilled syringes are expected to boost the growth of the Prefilled Syringes Market.
The market research study on Prefilled Syringes Market includes in-depth insights such as:
Prefilled Syringes Market in Europe held the largest market share in the year 2021.
Prefilled Syringes Market is classified based on the Product Type into Safety Prefilled Syringes, Conventional Prefilled Syringes.
Prefilled Syringes Market is classified based on the Material Type into Glass Prefilled Syringes, Plastic Prefilled Syringes.
Prefilled Syringes Market is classified based on the Closing System into Luer Lock System, Staked Needle System, Luer Cone System.
Prefilled Syringes Market is classified based on the Design into Customized Prefilled Syringes, Single-Chamber Prefilled Syringes, Dual- Chamber Prefilled Syringes.
Prefilled Syringes Market is classified based on the Application into Ophthalmology, Anaphylaxis, Diabetes, Rheumatoid Arthritis, Cancer, Thrombosis, Others.
Prefilled Syringes Market is classified based on the End User into Hospitals, Ambulatory Surgery Centers, Mail Order Pharmacies, Others.
Increasing demand for prefilled syringes containing biological products is expected to drive the growth of the Prefilled Syringes Market.
“The advantages offered by prefilled syringes like accurate dosing is expected to boost the growth of the Prefilled Syringes Market”, said a lead analyst at Fatpos Global.
Prefilled syringes are injectable drug delivery system introduced to operate drugs via the parenteral route. Prefilled syringes are one of the effective drug delivery system to administer several injectable drugs like biologics and biosimilar which is expected to create demand for prefilled syringes. Prefilled syringes are easy to administer and assist in quick delivery of drugs. Several advancements in product are resulting in decreasing waste and including products to administer huge volumes of medications.
Download Free Sample Report: https://www.fatposglobal.com/sample-request/prefilled-syringes-market-1501
Prefilled Syringes Market is classified based on the Material Type into Glass Prefilled Syringes, Plastic Prefilled Syringes. Glass segment dominated the market in 2021 owing to the robust barrier property of the glass which is used for manufacturing of prefilled syringes. The benefits of being compatible with several filling drug machines may also aid in the market growth. Plastic segment is expected to dominate the market due to the high preference of the glass ions to react with drugs and the fragile nature of glass which is to be altered with plastic and is expected to boost the growth of the market in the forecast period.
Key Players in the Market
Some of the key players operating in the Prefilled Syringes Market are Bayer AG, Abbott Laboratories, Becton, Baxter International, Gerresheimer Ag, Vetter Pharma International Gmbh, Nipro Corporation, Terumo Medical Corporation, West Pharmaceutical Services, Inc and Other Prominent Players.
Get Valuable Insights into Market
In the latest market study conducted by Fatpos Global thrives to present an unbiased analysis of the Market that covers the historical demand data as well as the forecast figures for the period, i.e., 2022–2032. The study includes compelling insights into growth that is witnessed in the Market. Prefilled Syringes Market is classified based on the Product Type into Safety Prefilled Syringes, Conventional Prefilled Syringes. Prefilled Syringes Market is classified based on the Material Type into Glass Prefilled Syringes, Plastic Prefilled Syringes. Prefilled Syringes Market is classified based on the Closing System into Luer Lock System, Staked Needle System, Luer Cone System. Prefilled Syringes Market is classified based on the Design into Customized Prefilled Syringes, Single-Chamber Prefilled Syringes, Dual- Chamber Prefilled Syringes. Prefilled Syringes Market is classified based on the Application into Ophthalmology, Anaphylaxis, Diabetes, Rheumatoid Arthritis, Cancer, Thrombosis, Others. Prefilled Syringes Market is classified based on the End User into Hospitals, Ambulatory Surgery Centers, Mail Order Pharmacies, Others. Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and Middle East and Africa.
About us
An acronym for “Failures Are the Pillar of Success”, FATPOS Global has grown to become an end-to-end market intelligence firm. At FATPOS Global, we have emerged to become a reliable market research and management consulting company that caters to non-profits, corporations, and government agencies. Our aim is to help organizations make the right decisions backed by reliable data, in order to help them meet their growth goals.
Contact Us
74/1, Bindal Chowk, Paltan Bazaar, Dehradun,
Uttarakhand 248001, India
+91 (135) 3501691
Email :[email protected]
Website : https://www.fatposglobal.com
0 notes
Text
Human Insulin Market to reach USD 33.38 billion in 2030
Human Insulin Market, by product type (traditional human insulins, basal or long-acting insulins, bolus or fast-acting insulins, insulin combinations, and biosimilar insulins), Drugs (Biologics, Biosimilars), Brands (Lantus, NovoRapid, Humalog), Delivery Devices (Pens, Pen Needles, Syringes) Application (Type 1 Diabetes, Type 2 Diabetes) and region (North America, Europe, Asia-Pacific, Middle East and Africa and South America).
The global Human Insulin market size was estimated at USD 25.96 billion in 2023 and is projected to reach USD 33.38 billion in 2030 at a CAGR of 3.2% during the forecast period 2023-2030.
Human Insulin or Insulin is a hormone produced in the human pancreas that regulates the amount of glucose (sugar) in the bloodstream and the metabolism of fats, proteins and carbohydrates in the human body. Insulin is available in different strengths; the most common is U-100, which is used as a dietary and exercise supplement to improve glucose balance in children and adults.
The growth of the global market is attributed to key factors such as increasing demand for human insulin analogues and affordable reimbursements. Technological innovations in human insulin delivery devices are also boosting the market. For example, in August 2020, the US FDA approved the MiniMed 770G, an innovative diabetes management device. This device automatically monitors glucose levels and delivers the correct basal insulin doses to pediatric patients with type 1 diabetes with minimal client (caregiver) input.
The COVID-19 pandemic has significantly affected the human insulin drug market. Patients with type 1 diabetes were more affected during Covid-19. Diabetics have a weak immune system, so in case of COVID-19, the immune system weakens very quickly. Diabetics are more likely to develop serious complications than the general population. In the midst of the pandemic, there have been delays and disruptions in the supply of medicines due to strategies designed to contain the spread of SARS-CoV-2. In addition, hospitals reported a decrease in insulin prescriptions. However, in several countries, the impact of COVID-19 decreased after the second quarter of 2021, helping the market to pull back.
Request for the Research Copy: https://www.delvens.com/get-free-sample/human-insulin-market-trends-forecast-till-2030
Delvens Industry Expert's Standpoint
The global market is driven by advances in technology, increasing R&D funding, increasing government support and prevalence of diabetes. In addition, R&D's role in the insulin market is increasing as researchers around the world strive to develop a better insulin molecule for diabetics that increases efficacy and reduces side effects. In addition, the market is expected to grow in the absence of drug cap rules, which will result in several major pharmaceutical companies raising the prices of generic drugs, including insulin. Global market players can also capitalize on the opportunities in the premixed insulin segment due to its ease of use and portability, as well as premixed insulin delivery devices.
Key Findings
By product, the human insulin market is divided into two main segments: drugs and dosing devices. The human insulin drug segment is expected to account for the largest share of the global market by product in 2022. Behind this high share is, among other things, the growth of the population with diabetes worldwide, the increasing research and development of drug research and development, and the growing share of the aging population. population trends in developed countries, increased access to generic human insulin products worldwide, and government initiatives to support the development and commercialization of effective biosimilars.
The application segment is further bifurcated into type-1 and type-2 diabetes. The largest segment by application is type 1 diabetes mellitus, due to the high insulin dependency of these patients. It is a more severe condition than type 2 diabetes. According to the International Diabetes Federation, around 10% of all individuals with diabetes have type-1 diabetes.
By product type, the human insulin device market is divided into three segments: pens, pen needles and syringes. The pen segment is expected to account for the largest market share in 2022; it will be the fastest growing segment in the next five years. Its rapid growth is due to the increasing market focus of ballpoint pen manufacturers moving towards insulin pen production on developing countries such as China, India and Brazil; significant medical benefits for human insulin pens in mature markets such as the US and Europe; and continued product development and product marketing of innovative human insulin pens.
The market is also divided into various regions such as North America, Europe, Asia-Pacific, South America, and Middle East and Africa. North America is estimated to account for the largest market share during the forecast period. In North America due to the dominance of branded products and the increasing prevalence of disease in the region.
Regional Analysis
North America to Dominate the Market
North America is estimated to account for the largest market share during the forecast period due to the dominance of branded products and the increasing prevalence of disease in the region.
Moreover, the strong presence of some of major players Novo Nordisk A/S, Eli Lilly and Company, and Sanofi is expected to boost the North American market growth.
Make an Inquiry Before Purchase: https://www.delvens.com/Inquire-before-buying/human-insulin-market-trends-forecast-till-2030
Competitive Landscape
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Pfizer Inc.
Biocon Ltd
Wockhardt
Boehringer Ingelheim International GmbH
Julphar
United Laboratories International Holdings Limited
Tonghua Dongbao Pharmaceutical Co. Ltd.
Exir
Sedico
Bristol-Myers Squibb Company
GlaxoSmithKline Plc
Oramed
Adocia
Merck & co. Inc
Recent Developments
November 2022: The U.S. Food and Drug Administration approved Tzield (teplizumab-mzwv) injection to delay the onset of stage 3 type-1 diabetics and pediatric patients 8 years of age and older who were stage 2 type-1 diabetics.
May 2022: The FDA approved Lilly’s new medication Mounjaro (also known as tirzepatide) for type-2 diabetes management in addition to diet and exercise. This first-in-class medication showed improvement in glucose levels and also dramatically improved weight in clinical trials.
Reasons to Acquire
Increase your understanding of the market for identifying the most suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors.
Gain authentic and granular data access for the Human Insulin Market to understand the trends and the factors involved in changing market situations.
Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future.
In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns.
Direct Order for the Research Report: https://www.delvens.com/checkout/human-insulin-market-trends-forecast-till-2030
Report Scope
The Human Insulin Market is segmented into various segments such as product type, brands, delivery devices, application, drugs and region:
Based on product type
traditional human insulins
Novolin/Actrapid/Insulatard
Humulin
Insuman
basal or long-acting insulins
Lantus
Levemir
Toujeo
Tresiba
Basaglar
bolus or fast-acting insulins
NovoRapid/Novolog
Humalog
Apidra
FIASP
Admelog
insulin combinations
NovoMix
Ryzodeg
Xultophy
Soliqua/Suliqua
biosimilar insulins
Insulin Glargine Biosimilars
Human Insulin Biosimilars
Based on the Brands
Lantus
NovoRapid
Humalog
Based on the Delivery Devices
Pens
Reusable
Disposable
Pen Needles
Standard
Safety
Syringes
Based on drugs
Biologics
Biosimilars
Based on Application
Type 1 Diabetes
Type 2 Diabetes
Based on region
Asia Pacific
Japan
China
India
Australia
South Korea
Vietnam
New Zealand
Philippines
Thailand
Malaysia
Hong Kong
Taiwan
Singapore
Indonesia
Sri Lanka
Rest of Asia-Pacific
North America
U.S.
Canada
Mexico
Europe
Germany
U.K.
France
Italy
Spain
Sweden
Austria
Finland
Belgium
Turkey
Russia
Poland
Hungary
Czech Republic
Switzerland
Netherlands
Rest of Europe
South America
Brazil
Argentina
Chile
Colombia
Rest of South America
Middle East & Africa
South Africa
U.A.E.
Saudi Arabia
Oman
Qatar
Iran
Egypt
Rest of Middle East and Africa
The prominent players in the Human Insulin market are
Novo Nordisk A/S
Eli Lilly and Company
Sanofi
Pfizer Inc.
Biocon Ltd
Wockhardt
Boehringer Ingelheim International GmbH
Julphar
United Laboratories International Holdings Limited
Tonghua Dongbao Pharmaceutical Co. Ltd.
Exir
Sedico
Bristol-Myers Squibb Company
GlaxoSmithKline Plc
Oramed
Adocia
Merck & co. Inc
About Us:
Delvens is a strategic advisory and consulting company headquartered in New Delhi, India. The company holds expertise in providing syndicated research reports, customized research reports and consulting services. Delvens qualitative and quantitative data is highly utilized by each level from niche to major markets, serving more than 1K prominent companies by assuring to provide the information on country, regional and global business environment. We have a database for more than 45 industries in more than 115+ major countries globally.
Delvens database assists the clients by providing in-depth information in crucial business decisions. Delvens offers significant facts and figures across various industries namely Healthcare, IT & Telecom, Chemicals & Materials, Semiconductor & Electronics, Energy, Pharmaceutical, Consumer Goods & Services, Food & Beverages. Our company provides an exhaustive and comprehensive understanding of the business environment.
Contact Us:
UNIT NO. 2126, TOWER B,
21ST FLOOR ALPHATHUM
SECTOR 90 NOIDA 201305, IN
+44-20-8638-5055
0 notes
Text
IV Tubing Sets and Accessories Market Study: An Emerging Hint of Opportunity by 2032
The IV tubing sets and accessories market plays a vital role in the healthcare industry by ensuring the safe and efficient delivery of intravenous fluids and medications to patients. These sets and accessories form an integral part of the healthcare system, facilitating accurate and controlled administration of fluids, drugs, and blood products. As advancements in medical technology continue to emerge, the IV tubing sets and accessories market is experiencing significant growth, driven by the increasing demand for efficient and reliable infusion systems.
One of the key factors contributing to the growth of the market is the rising prevalence of chronic diseases and the subsequent need for long-term intravenous therapies. Conditions such as cancer, diabetes, and autoimmune disorders require continuous administration of medications and fluids, creating a substantial demand for reliable and versatile IV tubing sets and accessories. Additionally, the growing aging population and the increasing number of surgical procedures are further fueling the demand for these products.
Moreover, technological advancements are revolutionizing the IV tubing sets and accessories market. Manufacturers are focusing on developing innovative products that enhance patient safety, reduce the risk of contamination, and improve overall workflow efficiency. These advancements include features such as antimicrobial coatings, needle-free connectors, and advanced flow control mechanisms, ensuring accurate medication delivery and minimizing the potential for adverse events.
Furthermore, the market is witnessing significant expansion due to the surge in healthcare facilities, both in developed and developing regions. The establishment of hospitals, clinics, and ambulatory care centers, coupled with the growing investments in healthcare infrastructure, is driving the demand for IV tubing sets and accessories. Additionally, the increasing awareness about the importance of infection control and patient safety is further propelling the adoption of these products.
For More Info@ https://www.prnewswire.com/news-releases/iv-tubing-sets-and-accessories-market-value-is-expected-to-reach-us-1248-million-by-2025---persistence-market-research-663616243.html
In conclusion, the IV tubing sets and accessories market is experiencing robust growth due to the increasing prevalence of chronic diseases, technological advancements, and the expansion of healthcare facilities. The market is poised to continue its upward trajectory as healthcare providers seek reliable and innovative solutions for intravenous therapy. With a focus on patient safety, efficiency, and infection control, the market is expected to witness sustained growth in the coming years, contributing to the advancement of healthcare delivery and patient outcomes.
0 notes
Text
0 notes
Text
Self-Injection Devices Market 2022 | Cancer Segment Anticipated To Gain Highest Industry Share
The global self-injection devices market size is expected to reach USD 10.8 billion by 2030, according to a new report by Grand View Research, Inc. It is projected to expand at a CAGR of 5.7% from 2022 to 2030. Increasing patient volume and rising prevalence of chronic diseases along with the high adoption of advanced drug delivery systems are factors estimated to surge the demand for self-injection devices.
Prevention of needlestick injury is a primary factor for healthcare professionals and companies to introduce self-injection devices such as autoinjectors. To avoid needlestick injuries to healthcare workers, the U.S., Europe, and other markets mandate the use of safety devices. Several auto-injectors provide the additional benefit of needlestick protection to healthcare professionals. It is expected that in the U.S. about 69,000 injuries can be prevented annually. Numerous auto-injectors have integral and passive safety features that eliminate or reduce the risk of injury.
Gain deeper insights on the market and receive your free copy with TOC now @: Self-injection Devices Market Report
Innovation in the field of New Drug Delivery Systems (NDDDS) has led to the rising demand for self-administered medications. The invention of novel injectable delivery devices such as pre-filled syringes, pen injectors, autoinjectors, and needle-free injectors has made the self-administration of drugs easier and more convenient for patients. The majority of biological drugs are delivered using injections, which include the threat of needlestick injuries. To minimize this issue, pharmaceutical firms are developing self-administered needle-free injectors and patient-friendly medication-device combination products.
The COVID-19 pandemic has altered expectations and perceptions of delivery settings and contributed to a rise in preference for self-administration medication. As this becomes the norm, several manufacturers are inclined to make the patient experience the vital component of drug delivery design. Significantly, the COVID-19 vaccines will increase the demand for injectable devices and the pandemic has also shown the benefit of self-use devices as well as connected devices. Post-pandemic there may be a rise in upcoming innovation in devices and pharma manufacturers will progressively collaborate to use self-injection devices in combination with other digital assets such as apps, phones, and personal computers. Eventually, this will bring the patient into far greater control of their care.
#Self-injection Devices Market Size & Share#Self-injection Devices Market Latest Trends#Self-injection Devices Market Growth Forecast#COVID-19 Impacts On Self-injection Devices Market#Self-injection Devices Market Revenue Value#Global Self-injection Devices Market
0 notes
Link
0 notes
Text
The global autoinjectors market is projected to grow at an annualized rate of over 10%
Autoinjectors have become an important part of modern healthcare, having demonstrated the potential to address a number of parenteral drug delivery related adverse events, and improve medication adherence among patients
Roots Analysis is pleased to announce the publication of its recent study, titled, “Global Autoinjectors Market (3rd Edition), 2020-2030.”
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of autoinjectors over the next decade. The report features an in-depth analysis, highlighting the diverse capabilities of stakeholders engaged in this domain. In addition to other elements, the study includes:
§ A detailed assessment of the current market landscape of developers engaged in the development and / or manufacturing autoinjectors.
§ A detailed assessment of current landscape of companies that are developing drugs in combination with autoinjectors.
§ A competitiveness analysis of various disposable and reusable autoinjectors.
§ A detailed brand positioning analysis of leading industry players highlighting the current perceptions regarding their proprietary brands.
§ A list of marketed drugs / therapies and pipeline candidates that are likely to be developed in combination with autoinjectors in the near future.
§ A list of key opinion leaders (KOLs) within this domain with significant contributions in clinical trials and filing patent applications.
§ Detailed case studies on the most commonly targeted indications of the approved autoinjector products.
§ A case study on the role of CMOs offering services for drug delivery devices.
§ A SWOT analysis capturing the key parameters and trends that are likely to influence the future of autoinjectors market.
§ Elaborate profiles of autoinjector manufacturers that have more than three devices in their respective product portfolios.
§ A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Usability
§ Disposable
§ Reusable
Route of Administration
§ Subcutaneous
§ Intramuscular
Type of Molecule
§ Monoclonal Antibody
§ Peptide
§ Protein
§ Small Molecule
Therapeutic Indication
§ Anaphylaxis
§ Asthma
§ Multiple Sclerosis
§ Rheumatoid Arthritis
§ Migraine
§ Diabetes
§ Other Indications
Key Geographies
§ North America
§ Europe
§ Asia-Pacific
§ Rest of the World
The research, analysis and insights presented in this report are backed by a deep understanding of key insights gathered from both secondary and primary research. The opinions and insights presented in the report were influenced by discussions held with several players in this industry. The study includes detailed transcripts of discussions held with the following individuals:
§ David Daily (CEO and Co-founder, DALI Medical Devices)
§ Dennis Lee (Senior Program Officer in CMC, Bill & Melinda Gates Foundation)
§ Douglas Marenzi (Managing Director, PHC Injection Technologies)
§ Tsachi Shaked (Senior Marketing and BD Director, Injectable Drug Delivery Devices, Elcam Medical)
§ Jesse Fourt (Design Director, IDEO)
Key companies covered in the report
§ Antares Pharma
§ Consort Medical (Previously Bespak)
§ DALI Medical Devices
§ Elcam Medical (E3D Elcam Drug Delivery Devices)
§ Jiangsu Delfu Medical Devices
§ Oval Medical Technologies
§ Owen Mumford
§ SHL Group
§ Union Medico®
§ Ypsomed
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/autoinjectors-market/293.html
Other Recent Offerings
1. Prefilled Syringes Market (5th Edition), 2019-2030
2. Novel Vaccine Delivery Devices Market, 2019-2030
3. Microneedles and Needle-Free Injection Systems / Jet Injectors (Devices based on Spring, Gas and Other Mechanisms) Market, 2019-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at [email protected]
Contact Information
Roots Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
+44 (122) 391 1091
0 notes
Last Seen Blogs
the-space-cadet-old-school
Untitled
hoshitakemushrooms
uhhh i love seventeen
lcruthers
someone's gotta stay
speedycollectorgarden-3e8e8-blog
Sem título
mazzii
Skyrim Shenanigans